Growth Metrics

Nexgel (NXGL) Current Deferred Revenue (2020 - 2025)

Nexgel (NXGL) has disclosed Current Deferred Revenue for 5 consecutive years, with $180000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Deferred Revenue rose 0.56% year-over-year to $180000.0, compared with a TTM value of $180000.0 through Sep 2025, up 0.56%, and an annual FY2024 reading of $179000.0, up 795.0% over the prior year.
  • Current Deferred Revenue was $180000.0 for Q3 2025 at Nexgel, roughly flat from $180000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $286000.0 in Q1 2025 and bottomed at $20000.0 in Q4 2023.
  • Average Current Deferred Revenue over 4 years is $152500.0, with a median of $179000.0 recorded in 2024.
  • The sharpest move saw Current Deferred Revenue soared 795.0% in 2024, then increased 0.56% in 2025.
  • Year by year, Current Deferred Revenue stood at $38000.0 in 2021, then crashed by 47.37% to $20000.0 in 2023, then surged by 795.0% to $179000.0 in 2024, then rose by 0.56% to $180000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for NXGL at $180000.0 in Q3 2025, $180000.0 in Q2 2025, and $286000.0 in Q1 2025.